Nkarta, Inc.

Ownership Transactions Reported by 20 Insiders

Symbol
NKTX on Nasdaq
Industry
Pharmaceutical Preparations
Location
1150 Veterans Boulevard, South San Francisco, CA

Insiders trading volume in the past year

Nkarta, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
James Trager Chief Scientific Officer $845K Jun 18, 2024
Paul J. Hastings Chief Executive Officer, Director $573K -$41.4K -6.74% Jun 18, 2025
Nadir Mahmood President $477K Jun 5, 2025
David Shook Chief Medical Officer, Head of Research & Development $420K -$19K -4.33% Jan 15, 2025
Alicia Hager Chief Legal Officer $323K -$21.1K -6.13% Jan 15, 2025
Ralph Brandenberger Chief Technical Officer $275K -$16.4K -5.63% Jan 15, 2025
Alyssa Levin Chief Financial and Business Officer $226K -$12.8K -5.38% Jan 15, 2025
Kanya Rajangam Chief Medical Officer $112K Jan 14, 2022
Angela Thedinga Director Jun 5, 2025
Leone D. Patterson Director Jun 5, 2025
Shawn Marshall Rose Chief Medical Officer, Head of Research & Development Jun 23, 2025
Simeon George Director Jun 5, 2025
Ra Capital Management, L.P. Director, 10%+ Owner Jun 5, 2025
Michael Dybbs Director Jun 5, 2025
Tiba Aynechi Director Jun 8, 2022
Zachary Scheiner Director Jun 5, 2025
Fouad Oscar Azzam Director Jun 7, 2023
Ali Behbahani Director Jun 5, 2025
George Vratsanos Director Jun 5, 2025
Laura Shawver Director Jun 8, 2022

Recent Insider Transactions by Companies or Individuals for Nkarta, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.